id: phenobarbital_protocol_to_hospital_length_of_stay
name: Phenobarbital-Based Treatment Protocol â†’ Hospital Length of Stay
from_node:
  node_id: phenobarbital_protocol
  node_name: Phenobarbital-Based Treatment Protocol
to_node:
  node_id: hospital_length_of_stay
  node_name: Hospital Length of Stay
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Phenobarbital-based protocol implemented as monotherapy for alcohol withdrawal
  syndrome on general medical units'
- 'Step 2: Phenobarbital provides longer-acting GABA-mediated sedation compared to
  short-acting benzodiazepines'
- 'Step 3: Reduced need for frequent medication dosing and symptom monitoring allows
  for more efficient withdrawal management'
- 'Step 4: Patients achieve clinical stability more rapidly, reducing time to discharge
  readiness'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Fadi Hawa et al. 2021. "Phenobarbital Versus Lorazepam for Management
    of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study." *Cureus*. https://doi.org/10.7759/cureus.13282'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.703493'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
